In this episode, Pilar Fernandez Hermida – International Go-To-Market Expert with 20+ years of experience launching sales & partner ecosystem strategies, talks about: The potential of the Middle East and MENA region for healthtech…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
A clinical trial can cost hundreds of millions of dollars, and one of the major contributors to costs is recruiting and keeping human subjects. According to Dr. Raviv Pryluk, PhD, CEO and co-founder at…
Continue Reading
What You Should Know:
– Absci Corporation (Nasdaq: ABSI), a company utilizing generative AI for drug discovery, announced today an initial public offering (IPO) of $75 million in common stock.
– This IPO aims to support…
Continue Reading
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence…
Continue Reading
Publicly listed Daewoong Pharmaceutical has recently unveiled its AI-driven drug development system, powered by a database of hundreds of millions of pre-processed compounds. WHAT IT’S ABOUT
Over the past two years, researchers of the Seoul-based pharma…
What You Should Know:
Personalis, Inc., a leader in advanced genomics for cancer, and ClearNote Health, Inc., a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by…
Continue Reading
What You Should Know:
– Deliberate AI, a digital health company harnessing AI to revolutionize mental health assessment, has secured a major milestone in its mission. The U.S. Food and Drug Administration (FDA) has selected…
Continue Reading
Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and…
Continue Reading
What You Should Know:
– Debiopharm, a leading independent biopharmaceutical company, and ThinkingNodeLife.ai (TNL), a pioneer in AI-powered drug discovery, today announced a groundbreaking partnership to propel the development of a cutting-edge cancer drug.
– This…
Continue Reading
